You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 145 No. 12, December 1985 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (81)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Prophylaxis Against Repeated Radiocontrast Media Reactions in 857 Cases

Adverse Experience With Cimetidine and Safety of β-Adrenergic Antagonists

Paul A. Greenberger, MD; Roy Patterson, MD; Charlene M. Tapio

Arch Intern Med. 1985;145(12):2197-2200.


Abstract



• Eight hundred fifty-seven radiocontrast media (RCM) procedures were performed from 1974 to 1984 in 743 patients who previously had experienced an immediate generalized (anaphylactoid) reaction to RCM. During the 695 intravascular infusions of RCM, prednisone—diphenhydramine hydrochloride pretreatment of 415 essential repeated RCM procedures from 1974 to 1980 resulted in 45 (10.8%) reactions during which transient hypotension occurred in three (0.7%) patients. From 1980 to 1983, prednisone-diphenhydramine-ephedrine sulfate pretreatment of 180 procedures was associated with only nine reactions (5.0%) ({chi}2 = 5.195). The addition of cimetidine hydrochloride in 1983 to 1984 was not useful in that 14 reactions occurred during 100 procedures (14.0%). The 21 patients who had been receiving β-adrenergic antagonist therapy were protected as well as those who were not, in that none of 11 patients receiving the three-drug regimen had a repeated reaction and only one of ten patients receiving the four-drug regimen reacted.

(Arch Intern Med 1985;145:2197-2200)



Author Affiliations



From the Section of Allergy-Immunology, Department of Medicine, Northwestern University Medical School and the Drug Information Center, Northwestern Memorial Hospital, Chicago.


Footnotes



Accepted for publication Feb 14, 1985.

Reprint requests to Section of Allergy-Immunology, Northwestern University, 303 E Chicago Ave, Chicago, IL 60611 (Dr Greenberger).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Levine et al.
J Am Coll Cardiol 2011;58:e44-e122.
FULL TEXT  

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Levine et al.
J Am Coll Cardiol 2011;58:2550-2583.
FULL TEXT  

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Writing Committee Members et al.
Circulation 2011;124:e574-e651.
FULL TEXT  

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Writing Committee Members et al.
Circulation 2011;124:2574-2609.
FULL TEXT  

Repeat Contrast Medium Reactions in Premedicated Patients: Frequency and Severity
Davenport et al.
Radiology 2009;253:372-379.
ABSTRACT | FULL TEXT  

Management of Patients with History of Adverse Effects to Contrast Media When Pulmonary Artery CT Angiography Is Required
Bierry et al.
Radiology 2007;245:919-921.
FULL TEXT  

Management of Patients Undergoing Percutaneous Coronary Revascularization
Levine et al.
ANN INTERN MED 2003;139:123-136.
ABSTRACT | FULL TEXT  

Dexamethasone prophylaxis for paclitaxel hypersensitivity
Gilbar and Ridge
J Oncol Pharm Pract 2002;8:81-87.
ABSTRACT  

ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions
Scanlon et al.
J Am Coll Cardiol 1999;33:1756-1824.
FULL TEXT  

Increased Risk for Anaphylactoid Reaction from Contrast Media in Patients on {beta}-Adrenergic Blockers or with Asthma
Lang et al.
ANN INTERN MED 1991;115:270-276.
ABSTRACT  

An Immediate Generalized Reaction to Iopamidol
Greenberger et al.
Arch Intern Med 1987;147:2208-2209.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.